Prudential Financial Inc. Decreases Stake in Encompass Health Co. (NYSE:EHC)

Prudential Financial Inc. lowered its holdings in Encompass Health Co. (NYSE:EHC) by 27.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,081 shares of the company’s stock after selling 4,859 shares during the quarter. Prudential Financial Inc.’s holdings in Encompass Health were worth $1,021,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Citigroup Inc. raised its stake in shares of Encompass Health by 65.4% in the second quarter. Citigroup Inc. now owns 26,656 shares of the company’s stock worth $2,080,000 after purchasing an additional 10,540 shares during the last quarter. Public Employees Retirement System of Ohio raised its stake in shares of Encompass Health by 8.0% in the second quarter. Public Employees Retirement System of Ohio now owns 60,037 shares of the company’s stock worth $4,685,000 after purchasing an additional 4,459 shares during the last quarter. State of Alaska Department of Revenue raised its stake in shares of Encompass Health by 65.5% in the second quarter. State of Alaska Department of Revenue now owns 25,711 shares of the company’s stock worth $2,006,000 after purchasing an additional 10,179 shares during the last quarter. Meeder Asset Management Inc. raised its stake in shares of Encompass Health by 54.5% in the second quarter. Meeder Asset Management Inc. now owns 655 shares of the company’s stock worth $51,000 after purchasing an additional 231 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Encompass Health by 4.6% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 366,048 shares of the company’s stock worth $28,563,000 after purchasing an additional 15,942 shares during the last quarter. Hedge funds and other institutional investors own 91.28% of the company’s stock.

Several research firms have recently weighed in on EHC. Royal Bank of Canada boosted their price target on Encompass Health from $102.00 to $104.00 and gave the stock an “outperform” rating in a research note on Thursday, July 29th. Credit Suisse Group upped their price objective on Encompass Health from $96.00 to $98.00 and gave the company an “outperform” rating in a research report on Thursday, July 29th. Zacks Investment Research cut Encompass Health from a “buy” rating to a “hold” rating and set a $67.00 price objective for the company. in a research report on Tuesday, November 2nd. Truist Securities reduced their price objective on Encompass Health from $100.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, October 13th. Finally, Raymond James reduced their price objective on Encompass Health from $107.00 to $90.00 and set a “strong-buy” rating for the company in a research report on Tuesday, November 2nd. One investment analyst has rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $88.30.

NYSE:EHC opened at $62.86 on Thursday. The firm’s 50-day moving average is $64.42. Encompass Health Co. has a 52-week low of $60.85 and a 52-week high of $89.68. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 1.39. The company has a market capitalization of $6.25 billion, a price-to-earnings ratio of 15.48, a PEG ratio of 0.74 and a beta of 0.99.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, October 27th. The company reported $1.03 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.06 by ($0.03). Encompass Health had a net margin of 8.10% and a return on equity of 19.87%. The company had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.31 billion. During the same period in the prior year, the firm posted $0.78 EPS. The business’s revenue for the quarter was up 9.4% on a year-over-year basis. On average, equities analysts anticipate that Encompass Health Co. will post 4.33 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 18th. Stockholders of record on Monday, January 3rd will be paid a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.78%. The ex-dividend date is Friday, December 31st. Encompass Health’s dividend payout ratio (DPR) is 27.59%.

About Encompass Health

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.

Featured Story: Why Invest in Dividend Kings

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.